Electrophysiological Effects of Potential QT Prolonging Drugs
Clinical trial NCT05716854 · COMPLETED
Trial details
- NCT number
- NCT05716854
- Sponsor
- Food and Drug Administration (FDA)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-21
- Primary completion
- 2023-06-13
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.